Literature DB >> 2871949

The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones.

B J Looij, A C Nieuwenhuijzen Kruseman, A H Mudde, M Frölich, G P Piaditis, S C Hodgkinson, C McLean, A Grossman, D H Coy, L H Rees.   

Abstract

To determine whether the 29 amino-acid fragment of growth hormone releasing hormone (GHRH) can be combined with other hypothalamic releasing hormones in a single test of anterior pituitary reserve, the responses of anterior pituitary hormones to combinations of an i.v. bolus of GHRH(1-29)NH2 or saline with an i.v. bolus of either LH releasing hormone (LHRH) plus TRH, ovine CRH(oCRH) or saline were studied. Each infusion of GHRH(1-29)NH2 resulted in a rapid increment of the plasma GH value. Infusion of GHRH(1-29)NH2 also caused a small and transient rise in plasma PRL, but no change in the integrated PRL response. The combination of GHRH(1-29)NH2 with LHRH plus TRH caused a larger increment of peak and integrated plasma TSH levels than LHRH plus TRH alone. GHRH(1-29)NH2 did not affect the release of other anterior pituitary hormones after infusion with oCRH or LHRH plus TRH. Because of the finding of potentiation of the TSH-releasing activity of LHRH plus TRH by GHRH(1-29)NH2, the study was extended to the investigation of TSH release after infusion of TRH in combination with either GHRH(1-29)NH2 or GHRH(1-40). In this study the combination of TRH with both GHRH preparations also caused a larger increment of the peak and integrated plasma TSH levels than TRH alone. It is concluded that GHRH(1-29)NH2 possesses moderate PRL-releasing activity apart from GH-releasing activity. In addition, GHRH potentiates the TSH-releasing activity of TRH.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2871949     DOI: 10.1111/j.1365-2265.1986.tb00757.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  10 in total

1.  Combined use of vasopressin and synthetic hypothalamic releasing factors as test of anterior pituitary function.

Authors:  A Grossman; J A Wass; G M Besser
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-10

2.  Effect of simultaneous administration of GHRH (1-40) and TRH on GH, PRL and TSH secretion in normal man.

Authors:  M Giusti; A Lomeo; G Mazzocchi; R Torre; M Monachesi; P Sessarego; R Attanasio; G Giordano
Journal:  J Endocrinol Invest       Date:  1986-12       Impact factor: 4.256

3.  Circadian and pulsatile thyrotropin release in treated acromegalics.

Authors:  F Roelfsema; H de Boer; M Frölich
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

4.  Interaction of L-dopa and GHRH on GH secretion in normal men.

Authors:  J Alba-Roth; C von Creytz; G Mehltretter; J Schopohl; O A Müller; K von Werder
Journal:  J Endocrinol Invest       Date:  1989-12       Impact factor: 4.256

5.  The effect of GHRH on TSH release in rats in vivo and in vitro.

Authors:  B J Looij; A C Nieuwenhuijzen Kruseman; F Roelfsema; D van der Heide; R P Hoogma; J P Schröder-van der Elst
Journal:  J Endocrinol Invest       Date:  1995-03       Impact factor: 4.256

6.  Inhibitory influence of thyrotropin releasing hormone administration on growth hormone response to low doses of growth hormone-releasing hormone in normal man.

Authors:  A Zanoboni; M Gibillini; M R Cucchi; W Zanoboni Muciaccia; C Zanussi
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256

7.  Correlation between pituitary growth hormone reserve and degree of growth failure in children with short stature.

Authors:  S Kajiwara; N Igarashi; E Imura; T Sato
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

8.  Adult adrenoleukodystrophy: the clinical spectrum in a large Dutch family.

Authors:  C P Zwetsloot; G W Padberg; A P van Seters; P D Maaswinkel-Mooy; W Onkenhout
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

9.  A prospective study of hypothalamus pituitary function after cranial irradiation with or without radiosensitizing chemotherapy.

Authors:  T S Huang; S C Huang; M M Hsu
Journal:  J Endocrinol Invest       Date:  1994-09       Impact factor: 4.256

10.  Growth hormone releasing factors.

Authors:  R R Davies; D G Johnston
Journal:  J R Soc Med       Date:  1987-01       Impact factor: 18.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.